{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T14:00:37Z","timestamp":1784383237571,"version":"3.55.0"},"reference-count":93,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T00:00:00Z","timestamp":1566518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Both old age and institutionalization in aged care homes come with a significant risk of developing several long-term mental and neurological disorders, but there has been no definitive meta-analysis of data from studies to determine the pooled estimate of central nervous system (CNS) medicines use in aged care homes. We conducted this systematic review to summarize the use of CNS drugs among aged care home residents. Methods: MEDLINE, EMBASE, CINAHL, Scopus, and International Pharmaceutical Abstracts (IPA) databases were searched (between 1 January 2000 and 31 December 2018) to identify population-based studies that reported the use of CNS medicines in aged care homes. Pooled proportions (with 95% confidence interval), according to study location were calculated. Results: A total of 89 studies reported the use of CNS medicines use in aged care. The pooled estimate of CNS drug use varied according to country (from 20.3% in Ireland to 49.0% in Belgium) and region (from 31.7% in North America to 42.5% in Scandinavia). The overall pooled estimate of psychotropic medicines use was highest in Europe (72.2%, 95% CI, 67.1\u201377.1%) and lowest in the ANZ region (56.9%, 95% CI, 52.2\u201361.4%). The pooled estimate of benzodiazepines use varied widely, from 18.9% in North America to 44.8% in Europe. The pooled estimate of antidepressant use from 47 studies was 38.3% (95% CI 35.1% to 41.6%), with the highest proportion in North America (44.9%, 95% CI, 35.3\u201354.5%). Conclusion: The overall use of CNS drugs varied among countries, with studies from Australia New Zealand reporting the lowest use of CNS drugs. The criteria for prescribing CNS drugs in clinical practice should be evidence-based. The criteria should be used not to prohibit the use of the listed medications but to support the clinical judgement as well as patient safety.<\/jats:p>","DOI":"10.3390\/jcm8091292","type":"journal-article","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T04:38:23Z","timestamp":1566794303000},"page":"1292","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Use of Central Nervous System (CNS) Medicines in Aged Care Homes: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4058-2215","authenticated-orcid":false,"given":"Syed Shahzad","family":"Hasan","sequence":"first","affiliation":[{"name":"Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield HD1 3DH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Tabish Razi","family":"Zaidi","sequence":"additional","affiliation":[{"name":"School of Healthcare, University of Leeds, Leeds LS2 9JT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorabar Singh","family":"Nirwan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield HD1 3DH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1884-6648","authenticated-orcid":false,"given":"Muhammad Usman","family":"Ghori","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield HD1 3DH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farideh","family":"Javid","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield HD1 3DH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5674-2765","authenticated-orcid":false,"given":"Keivan","family":"Ahmadi","sequence":"additional","affiliation":[{"name":"Lincoln Medical School\u2014Universities of Nottingham and Lincoln, College of Science, Lincoln LN6 7TS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaheer- Ud-Din","family":"Babar","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield HD1 3DH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,8,23]]},"reference":[{"key":"ref_1","unstructured":"(2019, July 06). Global Age Watch Index 2015. Available online: https:\/\/www.helpage.org\/global-agewatch\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/JGP.0b013e3180cc2bd7","article-title":"Problem-solving therapy for late-life depression in home care: A randomized field trial","volume":"15","author":"Gellis","year":"2007","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1377\/hlthaff.2009.0535","article-title":"Long-term care: Who gets it, who provides it, who pays, and how much?","volume":"29","author":"Kaye","year":"2010","journal-title":"Health Aff. (Millwood)"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1017\/S1041610210000608","article-title":"Prevalence of psychiatric disorders among older adults in long-term care homes: A systematic review","volume":"22","author":"Seitz","year":"2010","journal-title":"Int. Psychogeriatr."},{"key":"ref_5","unstructured":"World Health Organization (2019, July 08). Mental Health of Older Adults. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/mental-health-of-older-adults."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hup.1160","article-title":"Geriatric drug utilisation of psychotropics in Belgian nursing homes","volume":"26","author":"Azermai","year":"2011","journal-title":"Hum. Psychopharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/gerona\/62.10.1172","article-title":"Medication as a risk factor for falls: Critical systematic review","volume":"62","author":"Hartikainen","year":"2007","journal-title":"J. Gerontol. Ser. A Biol. Sci. Med Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1017\/S104161020800714X","article-title":"The influence of drug use on fall incidents among nursing home residents: A systematic review","volume":"20","author":"Sterke","year":"2008","journal-title":"Int. Psychogeriatr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1532-5415.2008.02127.x","article-title":"Impact of Central Nervous System (CNS) Medication Use on Cognition Decline in Community Dwelling Older Adults: Findings from the Health, Aging and Body Composition Study","volume":"57","author":"Wright","year":"2009","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jad.2009.04.028","article-title":"A 12 months follow-up study of depression among nursing-home patients in Norway","volume":"120","author":"Barca","year":"2010","journal-title":"J. Affect Disord."},{"key":"ref_11","first-page":"264","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"ref_12","unstructured":"Scottish Intercollegiate Guidelines Network (2012). Methodology Checklist 3: Cohort Studies, Scottish Intercollegiate Guidelines Network."},{"key":"ref_13","unstructured":"(2019, July 02). MetaXL Version 5.3. Available online: https:\/\/www.epigear.com\/index_files\/metaxl.html."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2165\/00002512-200522090-00008","article-title":"Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland","volume":"22","year":"2005","journal-title":"Drugs Aging"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Mann, E., K\u00f6pke, S., Haastert, B., Pitkala, K., and Meyer, G. (2009). Psychotropic medication use among nursing home residents in Austria: A cross-sectional study. BMC Geriatr., 9.","DOI":"10.1186\/1471-2318-9-18"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"187.e7","DOI":"10.1016\/j.jamda.2011.03.007","article-title":"Prevalence of psychotropic medication use among German and Austrian nursing home residents: A comparison of 3 cohorts","volume":"13","author":"Richter","year":"2012","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"406.e13","DOI":"10.1016\/j.jamda.2011.09.004","article-title":"Antidepressant prescribing patterns in the nursing home: Second-generation issues revisited","volume":"13","author":"Shah","year":"2012","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_18","first-page":"320","article-title":"Cross-national comparison of medication use in Australian and Dutch nursing homes","volume":"46","author":"Taxis","year":"2017","journal-title":"Age Ageing"},{"key":"ref_19","first-page":"8","article-title":"Prevalence of different combinations of antiepileptic drugs and cns drugs in elderly home care service and nursing home patients in Norway","volume":"2016","author":"Halvorsen","year":"2016","journal-title":"Epilepsy Res. Treat."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/02813432.2018.1459164","article-title":"General practitioners\u2019 prescriptions of benzodiazepines, Z-hypnotics and opioid analgesics for elderly patients during direct and indirect contacts. A cross-sectional, observational study","volume":"36","author":"Sundseth","year":"2018","journal-title":"Scand. J. Prim. Health Care"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Auer, S.R., Hofler, M., Linsmayer, E., Berankova, A., Prieschl, D., Ratajczak, P., Steffl, M., and Holmerova, I. (2018). Cross-sectional study of prevalence of dementia, behavioural symptoms, mobility, pain and other health parameters in nursing homes in Austria and the Czech Republic: Results from the DEMDATA project. BMC Geriatr., 18.","DOI":"10.1186\/s12877-018-0870-8"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Helvik, A.S., Benth, J.S., Wu, B., Engedal, K., and Selbaek, G. (2017). Persistant use of psychotropic drugs in nursing home residents in Norway. BMC Geriatr., 17.","DOI":"10.1186\/s12877-017-0440-5"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jamda.2010.06.010","article-title":"Organization of the medication management process in Belgian nursing homes","volume":"12","author":"Verrue","year":"2011","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00228-018-02612-x","article-title":"Identifying potentially inappropriate prescribing in older people with dementia: A systematic review","volume":"75","author":"Hukins","year":"2019","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Westaway, K., Sluggett, J., Alderman, C., Moffat, A., Procter, N., and Roughead, E. (2018). The extent of antipsychotic use in Australian residential aged care facilities and interventions shown to be effective in reducing antipsychotic use: A literature review. Dementia (London), 28.","DOI":"10.1177\/1471301218795792"},{"key":"ref_26","unstructured":"National Institute for Health and Care Excellence (NICE) (2019, July 04). Managing Medicines in Care Homes (Guidelines 2018). Available online: https:\/\/www.nice.org.uk\/guidance\/sc1\/evidence\/full-guideline-pdf-2301173677."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00228-011-1188-z","article-title":"Benzodiazepine use in Belgian nursing homes: A closer look into indications and dosages","volume":"68","author":"Bourgeois","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/JGP.0b013e3181d6c0c6","article-title":"Antipsychotic and benzodiazepine use among nursing home residents: Findings from the 2004 National Nursing Home Survey","volume":"18","author":"Stevenson","year":"2010","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/11598420-000000000-00000","article-title":"Psychotropic drug-induced falls in older adults: A review of interventions aimed at reducing the problem","volume":"29","author":"Hill","year":"2012","journal-title":"Drugs Aging"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00228-014-1684-z","article-title":"Risk of hip fracture among older adults using anxiolytic and hypnotic drugs: A nationwide prospective cohort study","volume":"70","author":"Bakken","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2165\/00023210-200317110-00004","article-title":"Benzodiazepines and risk of hip fractures in older adults: A review of the evidence","volume":"17","author":"Cumming","year":"2003","journal-title":"CNS Drugs"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1001\/jamapsychiatry.2014.2190","article-title":"Why are benzodiazepines not yet controlled substances?","volume":"72","author":"Moore","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00198-013-2446-y","article-title":"Association between use of benzodiazepines and risk of fractures: A meta-analysis","volume":"25","author":"Xing","year":"2014","journal-title":"Osteoporos. Int."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0025-6196(12)60628-4","article-title":"Learning and memory impairment in older, detoxified, benzodiazepine-dependent patients","volume":"68","author":"Rummans","year":"1993","journal-title":"Mayo Clin. Proc."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0887-6177(03)00096-9","article-title":"Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: A meta-analysis","volume":"19","author":"Barker","year":"2004","journal-title":"Arch. Clin. Neuropsychol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1176\/ps.2010.61.7.655","article-title":"Datapoints: Psychotropic drug utilization among elderly nursing home residents in the United States","volume":"61","author":"Bhattacharjee","year":"2010","journal-title":"Psychiatr. Serv."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jamda.2012.09.002","article-title":"Indicators of benzodiazepine use in nursing home residents in France: A cross-sectional study","volume":"14","author":"Mathieu","year":"2013","journal-title":"J. Am. Med Dir. Assoc."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s40266-012-0002-7","article-title":"Comparison of prescription drug use between community-dwelling and institutionalized elderly in Sweden","volume":"29","author":"Johnell","year":"2012","journal-title":"Drugs Aging"},{"key":"ref_40","first-page":"251","article-title":"Medication use in residential care","volume":"32","author":"Kerse","year":"2005","journal-title":"N. Z. Fam. Physician"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jamda.2012.10.020","article-title":"Psychotropic medications and falls in nursing homes: A cross-sectional study","volume":"14","author":"Valle","year":"2013","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3325\/cmj.2011.52.16","article-title":"Psychotropic medication use among elderly nursing home residents in Slovenia: Cross-sectional study","volume":"52","year":"2011","journal-title":"Croat. Med. J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s40266-015-0336-z","article-title":"A multicomponent intervention to optimize psychotropic drug prescription in elderly nursing home residents: An Italian multicenter, prospective, pilot study","volume":"33","author":"Pasina","year":"2016","journal-title":"Drugs Aging"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"M505","DOI":"10.1093\/gerona\/56.8.M505","article-title":"The association of depression and mortality in elderly persons: A case for multiple, independent pathways","volume":"56","author":"Blazer","year":"2001","journal-title":"J. Gerontol. Ser. A Biol. Sci. Med Sci."},{"key":"ref_45","unstructured":"National Institute for Health and Care Excellence (2019, July 01). Depression in Adults: Recognition and Management. Available online: https:\/\/www.nice.org.uk\/guidance\/cg90."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/gps.591","article-title":"Hyponatraemia in elderly psychiatric patients treated with Selective Serotonin Reuptake Inhibitors and venlafaxine: A retrospective controlled study in an inpatient unit","volume":"17","author":"Kirby","year":"2002","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Gill, D., and Hatcher, S. (2000). Antidepressants for depression in adults with physical illness. Cochrane Database Syst. Rev., CD001312.","DOI":"10.1002\/14651858.CD001312"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/jama.288.6.701","article-title":"Sertraline treatment of major depression in patients with acute MI or unstable angina","volume":"288","author":"Glassman","year":"2002","journal-title":"JAMA"},{"key":"ref_49","first-page":"CD003491","article-title":"Antidepressants for depressed elderly","volume":"1","author":"Mottram","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/01.JGP.0000308883.64832.ed","article-title":"Efficacy of second generation antidepressants in late-life depression: A meta-analysis of the evidence","volume":"16","author":"Nelson","year":"2008","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jcgg.2013.12.001","article-title":"Happy pills in nursing homes in Belgium: A cohort study to determine prescribing patterns and relation to fall risk","volume":"5","author":"Verhoeven","year":"2014","journal-title":"J. Clin. Gerontol. Geriatr."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/gps.3902","article-title":"Trends in psychotropic drug prescribing in Norwegian nursing homes from 1997 to 2009: A comparison of six cohorts","volume":"28","author":"Ruths","year":"2013","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Gulla, C., Selbaek, G., Flo, E., Kjome, R., Kirkevold, O., and Husebo, B.S. (2016). Multi-psychotropic drug prescription and the association to neuropsychiatric symptoms in three Norwegian nursing home cohorts between 2004 and 2011. BMC Geriatr., 16.","DOI":"10.1186\/s12877-016-0287-1"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/JCP.0b013e31817d79eb","article-title":"Assessment of the prescription of antidepressant drugs in elderly nursing home patients: A clinical and laboratory follow-up investigation","volume":"28","author":"Almkvist","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00228-003-0679-y","article-title":"Psychotropic drugs in nursing- and old-age homes: Relationships between needs of care and mental health status","volume":"59","author":"Holmquist","year":"2003","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1017\/S1041610211001712","article-title":"Comparison of behavioral and psychological symptoms of dementia and psychotropic drug treatments among old adults in geriatric care in 2000 and 2007","volume":"23","author":"Gustafson","year":"2011","journal-title":"Int. Psychogeriatr."},{"key":"ref_57","first-page":"669","article-title":"Depression and use of antidepressants in Swedish nursing homes: A 12-month follow-up study","volume":"26","author":"Andersson","year":"2013","journal-title":"Int. Psychogeriatr."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.amjopharm.2011.03.001","article-title":"Prevalence and Predictors of Antidepressant Prescribing in Nursing Home Residents in the United States","volume":"9","author":"Karkare","year":"2011","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.sapharm.2013.10.003","article-title":"Quality of psychopharmacological medication use in nursing home residents","volume":"10","author":"Wei","year":"2014","journal-title":"Res. Soc. Adm. Pharm."},{"key":"ref_60","first-page":"625","article-title":"Prescribing psychoactive medications in nursing homes: Current practice in Singapore","volume":"44","author":"Mamun","year":"2003","journal-title":"Singap. Med. J."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/2042098616641355","article-title":"Factors associated with antidepressant use in residents with and without dementia in Australian aged care facilities","volume":"7","author":"Hiltunen","year":"2016","journal-title":"Ther. Adv. Drug Saf."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.amjopharm.2009.07.001","article-title":"Determinants of antidepressant medication prescribing in elderly residents of aged care homes in Australia: A retrospective study","volume":"7","author":"Nishtala","year":"2009","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1017\/S1041610211000445","article-title":"Patterns of psychotropic medication use in nursing homes: Surveys in Sydney, allowing comparisons over time and between countries","volume":"23","author":"Snowdon","year":"2011","journal-title":"Int. Psychogeriatr."},{"key":"ref_64","first-page":"18","article-title":"Use of psychotropic medicines in residential care facilities for older adults in Hawke\u2019s Bay, New Zealand","volume":"121","author":"Tucker","year":"2008","journal-title":"N. Z. Med. J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"850.e1","DOI":"10.1016\/j.jamda.2014.08.003","article-title":"Potentially inappropriate drug prescribing and associated factors in nursing homes","volume":"15","author":"Cool","year":"2014","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000355427","article-title":"Prevalence of depression among recently admitted long-term care patients in Norwegian nursing homes: Associations with diagnostic workup and use of antidepressants","volume":"37","author":"Iden","year":"2014","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/0269881113482530","article-title":"Risk of ischemic stroke with the use of risperidone, quetiapine and olanzapine in elderly patients: A population-based, case-crossover study","volume":"27","author":"Shin","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa0806994","article-title":"Atypical antipsychotic drugs and the risk of sudden cardiac death","volume":"360","author":"Ray","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1176\/jnp.11.3.392","article-title":"Olanzapine for psychosis in patients with Parkinson\u2019s disease with and without dementia","volume":"11","author":"Aarsland","year":"1999","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"ref_70","first-page":"5","article-title":"Using antipsychotic agents in older patients","volume":"65","author":"Alexopoulos","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00004714-200204000-00003","article-title":"Would a switch from typical antipsychotics to risperidone be beneficial for elderly schizophrenic patients? A naturalistic, long-term, retrospective, comparative study","volume":"22","author":"Barak","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"106S","DOI":"10.1038\/sj.npp.1395370","article-title":"The role of serotonin in antipsychotic drug action","volume":"21","author":"Meltzer","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2165\/00044011-200323050-00001","article-title":"Conventional and atypical antipsychotics in the elderly: A review","volume":"23","author":"Gareri","year":"2003","journal-title":"Clin. Drug Investig."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/070674370204700106","article-title":"Atypical antipsychotics: Mechanism of action","volume":"47","author":"Seeman","year":"2002","journal-title":"Can. J. Psychiatry"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/sj.npp.1301492","article-title":"ACNP White Paper: Update on use of antipsychotic drugs in elderly persons with dementia","volume":"33","author":"Jeste","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1517\/14656566.2.6.1033","article-title":"Ziprasidone: A new atypical antipsychotic","volume":"2","author":"Kech","year":"2001","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/00019442-200508000-00012","article-title":"Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia","volume":"13","author":"Deberdt","year":"2005","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1017\/S104161021100024X","article-title":"Assessment of antipsychotic prescribing in Belgian nursing homes","volume":"23","author":"Azermai","year":"2011","journal-title":"Int. Psychogeriatr."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archinte.165.11.1280","article-title":"The quality of antipsychotic drug prescribing in nursing homes","volume":"165","author":"Briesacher","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11845-008-0121-7","article-title":"Frequency and appropriateness of antipsychotic medication use in older people in long-term care","volume":"177","author":"Murphy","year":"2008","journal-title":"Ir. J. Med. Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1192\/bjp.176.6.563","article-title":"Effects of a pharmacist\u2019s medication review in nursing homes: Randomised controlled trial","volume":"176","author":"Furniss","year":"2000","journal-title":"Br. J. Psychiatry"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jamda.2015.01.092","article-title":"Organizational factors associated with inappropriate neuroleptic drug prescribing in nursing homes: A multilevel approach","volume":"16","author":"Vellas","year":"2015","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13584-016-0070-y","article-title":"The impact of facility characteristics on the use of antipsychotic medications in nursing homes: A cross-sectional study","volume":"5","author":"Frankenthal","year":"2016","journal-title":"Isr. J. Health Policy Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.seizure.2006.02.002","article-title":"Antiepileptic drug use in nursing home residents: A cross-sectional, regional study","volume":"15","author":"Huying","year":"2006","journal-title":"Seizure"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.seizure.2012.09.012","article-title":"Antiepileptic drug use in Austrian nursing home residents","volume":"22","author":"Huber","year":"2013","journal-title":"Seizure"},{"key":"ref_86","first-page":"609","article-title":"Experiencia cl\u00ednica de la pregabalina en el tratamiento de las epilepsias focales","volume":"40","year":"2005","journal-title":"Rev. Neurol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.eplepsyres.2003.08.009","article-title":"Levetiracetam does not alter body weight: Analysis of randomized, controlled clinical trials","volume":"56","author":"Gidal","year":"2003","journal-title":"Epilepsy Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2005.09.031","article-title":"Antiepileptic drug use and epileptic seizures in elderly nursing home residents: A survey in the province of Pavia, Northern Italy","volume":"68","author":"Galimberti","year":"2006","journal-title":"Epilepsy Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.eplepsyres.2015.11.009","article-title":"Antiepileptic drug use and epileptic seizures in nursing home residents in the Province of Pavia, Italy: A reappraisal 12 years after a first survey","volume":"119","author":"Galimberti","year":"2016","journal-title":"Epilepsy Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00228-011-1051-2","article-title":"Antiepileptic drug use in community-dwelling and institutionalized elderly: A nationwide study of over 1 300 000 older people","volume":"67","author":"Johnell","year":"2011","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_91","unstructured":"National Institute for Health and Care Excellence (NICE) (2019, July 02). Parkinson\u2019s Disease in Adults: Diagnosis and Management. Available online: https:\/\/www.nice.org.uk\/guidance\/ng71\/documents\/short-version-of-draft-guideline."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Ahlskog, J.E. (2009). Parkinson\u2019s Disease Treatment Guide for Physicians, Oxford University Press.","DOI":"10.1093\/oso\/9780195371772.001.0001"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2217\/nmt.14.22","article-title":"Prevention of falls in Parkinson\u2019s disease: A review of fall risk factors and the role of physical interventions","volume":"4","author":"Canning","year":"2014","journal-title":"Neurodegener. Dis. Manag."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/9\/1292\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:13:33Z","timestamp":1760188413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/9\/1292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,23]]},"references-count":93,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9]]}},"alternative-id":["jcm8091292"],"URL":"https:\/\/doi.org\/10.3390\/jcm8091292","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,23]]}}}